tiprankstipranks
BeOne Medicines (ONC)
NASDAQ:ONC
US Market
ONC
BeOne Medicines
RESEARCH TOOLSreports
Want to see ONC full AI Analyst Report?

BeOne Medicines (ONC) Stock News & Sentiment

860 Followers
BeOne Wins FDA Nod for BEQALZI Lymphoma Therapy
Premium
Company Announcements
BeOne Wins FDA Nod for BEQALZI Lymphoma Therapy
2d ago
8K
ONC
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
Premium
Ratings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
2M ago
ONC
BeOne Medicines Advances Combo Cancer Pill With Completed Phase 1 Bioavailability Study
Premium
Company Announcements
BeOne Medicines Advances Combo Cancer Pill With Completed Phase 1 Bioavailability Study
2M ago
ONC
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
Premium
Company Announcements
BeOne Medicines Advances BG-A3004 Into First-in-Human Skin Disease Trial: What Investors Should Watch
2M ago
ONC
Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne Medicines (ONC)
Premium
Company Announcements
Early Cancer Drug Trial Termination Highlights Pipeline Risk for BeOne Medicines (ONC)
2M ago
ONC
BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors
Premium
Company Announcements
BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors
2M ago
ONC
Beigene, Ltd. (ONC) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Beigene, Ltd. (ONC) Q4 Earnings Cheat Sheet
3M ago
ONC
More ONC News >

ONC News on the Web

Baker Bros. Advisors LP Increases Stake in Incyte Corp with Strategic Acquisition
GuruFocus News
Neutral
BeOne Wins FDA Nod for BEQALZI Lymphoma Therapy
TipRanks News
Bullish
BeOne Medicines price target raised to $367 from $364 at Leerink
TipRanks News
Bullish
Leerink Partners Keeps Their Buy Rating on BeOne Medicines (ONC)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: IQVIA Holdings (IQV), BeOne Medicines (ONC) and Nektar Therapeutics (NKTR)
TipRanks News
Bullish
BeOne Medicines’ Beqalzi granted accelerated approval by FDA
TipRanks News
Bullish
BeOne Medicines Ltd (6160) Gets a Buy from CMBC International
TipRanks News
Bullish
UBS Reaffirms Their Buy Rating on BeOne Medicines Ltd (6160)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ONC
Sector Average
Media Buzz
This Week7 articles
Weekly Average6.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ONC’s Media Buzz Sentiment?
7 articles about ONC were published this week. In an average week, 6.25 articles are published.
    What is ONC’s weekly average amount of articles?
    In an average week, 6.25 articles about ONC are published.
      What is ONC’s News Sentiment?
      100% of articles about ONC were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week